Strategic reproductive health partnership secured in Japan
Manchester, UK – 8 October 2020: Yourgene Health (AIM: YGEN), a leading international molecular diagnostics group, announces it has entered into a 5-year strategic partnership with a blue chip Japanese multinational to provide Yourgene’s FlexTM Analysis Software (“Flex Software”) bioinformatics platform for a reproductive health project.
Yourgene and the Japanese partner (the “Partner”) have entered into a technology transfer agreement which provides the Partner with access to Yourgene’s bioinformatics platform, the FlexTM Analysis Software, and other associated knowhow (“Knowhow”). The Flex Software and Knowhow will enable the Partner to offer in-house bioinformatic analysis and clinical screening services to the Japanese market for a reproductive health application. Yourgene expects this partnership to deliver over USD2.5m of revenue over the contract life, as well as creating a benchmark clinical offering in this major world healthcare market.
Yourgene launched its Yourgene FlexTM Analysis Software, a medical grade, configurable bioinformatics software platform in October 2019, to support the Company's ambition to develop strategic in vitro diagnostic (IVD) product development partnerships and research collaborations with key industry players. The Flex Software allows the complex sequencing data, generated during lab workflow, to be analysed in order to produce a user friendly, easy to interpret report for clinicians, without the need for the geneticist or a bioinformation. The Partner will also take a licence for the Atlas Workflow Manager, which ensures a seamless sample tracking workflow that will link to the Flex Software.
The Company will update the market with further information in due course when the results of this collaboration are ready for commercial launch by the Partner in Japan.
For more information on Yourgene’s FlexTM Analysis Software please visit:
https://www.yourgene-health.com/yourgene-flex-analysis-software
Lyn Rees, CEO of Yourgene Health plc, commented: “We are delighted to have secured this key strategic partnership expanding and consolidating our geographical reach into Japan. This is a great endorsement of our analytical capabilities, and we are pleased to be able to customise these class-leading technology tools: Flex Software and Atlas Workflow Manager for our partner. We hope to develop future collaborations with this blue chip partner further across reproductive health and other fields.”
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
